Homologous proteins SAPCD2X1 and SAPCD2 have significantly different carcinogenic capacities in human colorectal cancer cells based on structural prediction and functional verification.

We discussed the expression and biological functions of the SAPCD2X1 protein in the HCT116 CRC cell line by bioinformatics analysis and prediction, and biological function verification. Spatial conformation models of SAPCD2X1 and SAPCD2 were predicted using the threading method, ensemble method, and several other protein structure prediction approaches. The conformational similarity between SAPCD2X1 and SAPCD2 was studied, and their functions were predicted. The biological experiments showed that SAPCD2X1 and SAPCD2 were overexpressed in CRC cells. SAPCD2X1-specific antibodies were prepared. The expressions of SAPCD2X1 and SAPCD2 were localized in cells using the immunofluorescence assay. The SAPCD2 and SAPCD2X1 overexpression models were validated using Western Blot and RT-qPCR. We successfully predicted the structures of the SAPCD2X1 and SAPCD2 proteins, and visualized them using the VDM software. It was predicted that the tertiary structure of SAPCD2X1 changed significantly compared with SAPCD2. Alteration of the biological functions of SAPCD2X1 was also predicted due to the changes in the spatial conformation of the protein. Anti-SAPCD2X1 antibody and SAPCD2X1-EGFP and SAPCD2-EGFP recombinant plasmids were established. The overexpression of the two proteins was induced in HCT116 cells using the recombinant plasmids, and verified by RT-qPCR and Western Blot. Meanwhile, the anti-SAPCD2X1 antibody was proved to have a high specificity. The immunofluorescence assay showed that SAPCD2X1 and SAPCD2 are mainly expressed in the cytoplasm. SAPCD2X1 and SAPCD2 exhibited significantly different biological functions in HCT116 cells. SAPCD2 is a carcinogenic protein, while SAPCD2X1 does not affect the proliferation, invasion, and migration of human CRC HCT116 cells.

[1]  S. Gorin.  Care of Cancer Survivors: Special Issues for Colorectal Cancer Survivors. , 2023, FP essentials.

[2]  F. Feng,et al.  The Generation and Application of Monoclonal Antibodies to Detect SAPCD2 Expression in Precancerous and Malignant Gastric Lesions. , 2023, Iranian journal of immunology : IJI.

[3]  A. Jemal,et al.  Colorectal cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.

[4]  Desheng Wei.  MiR-486-5p specifically suppresses SAPCD2 expression, which attenuates the aggressive phenotypes of lung adenocarcinoma cells. , 2022, Histology and histopathology.

[5]  Chi Zhang,et al.  Identification of ARHGEF38, NETO2, GOLM1, and SAPCD2 Associated With Prostate Cancer Progression by Bioinformatic Analysis and Experimental Validation , 2021, Frontiers in Cell and Developmental Biology.

[6]  Yang Zhang,et al.  Improving fragment-based ab initio protein structure assembly using low-accuracy contact-map predictions , 2021, Nature Communications.

[7]  Zhi-Yu Pan,et al.  YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2 , 2021, Cancer biology & therapy.

[8]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[9]  Hongyu Wang,et al.  Silencing SAPCD2 Represses Proliferation and Lung Metastasis of Fibrosarcoma by Activating Hippo Signaling Pathway , 2020, Frontiers in Oncology.

[10]  Jianguo Wang,et al.  PATIENTS AND METHODS: Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) Eur opean Rev iew for Med ical and Pharmacol ogical Sci ences SAPCD2 promotes invasiveness and migration ability of breast cancer cells via YAP/TAZ , 2022 .

[11]  Aron Marchler-Bauer,et al.  NCBI's Conserved Domain Database and Tools for Protein Domain Analysis , 2019, Current protocols in bioinformatics.

[12]  Frank DiMaio,et al.  Automatic structure prediction of oligomeric assemblies using Robetta in CASP12 , 2018, Proteins.

[13]  R. Xing,et al.  Depletion of p42.3 gene inhibits proliferation and invasion in melanoma cells , 2017, Journal of Cancer Research and Clinical Oncology.

[14]  Torsten Schwede,et al.  The SWISS-MODEL Repository—new features and functionality , 2016, Nucleic Acids Res..

[15]  Bo Yu,et al.  CDD/SPARCLE: functional classification of proteins via subfamily domain architectures , 2016, Nucleic Acids Res..

[16]  Junnian Zheng,et al.  Overexpression of p42.3 promotes cell proliferation, migration, and invasion in human gastric cancer cells , 2016, Tumor Biology.

[17]  Yibin Hao,et al.  Optimization and Corroboration of the Regulatory Pathway of p42.3 Protein in the Pathogenesis of Gastric Carcinoma , 2015, Comput. Math. Methods Medicine.

[18]  Junnian Zheng,et al.  p42.3: An abductor of cell cycle. , 2015, Anti-cancer agents in medicinal chemistry.

[19]  Narmada Thanki,et al.  CDD: NCBI's conserved domain database , 2014, Nucleic Acids Res..

[20]  Yun Cui,et al.  Role of C9orf140 in the promotion of colorectal cancer progression and mechanisms of its upregulation via activation of STAT5, β-catenin and EZH2. , 2014, Carcinogenesis.

[21]  R. Xing,et al.  Cell cycle‐dependent expression of p42.3 promotes mitotic progression in malignant transformed cells , 2014, Molecular carcinogenesis.

[22]  R. Xing,et al.  Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma. , 2013, World journal of gastroenterology.

[23]  Jianhua Zhang,et al.  p42.3 gene expression in gastric cancer cell and its protein regulatory network analysis , 2012, Theoretical Biology and Medical Modelling.

[24]  W. Tong,et al.  Identification and characterization of a novel p42.3 gene as tumor-specific and mitosis phase-dependent expression in gastric cancer , 2007, Oncogene.

[25]  Eva Thulin,et al.  The EF‐hand domain: A globally cooperative structural unit , 2002, Protein science : a publication of the Protein Society.

[26]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[27]  C Combet,et al.  NPS@: network protein sequence analysis. , 2000, Trends in biochemical sciences.

[28]  Christophe Geourjon,et al.  SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments , 1995, Comput. Appl. Biosci..

[29]  Clinical significance of UGT1A1 gene polymorphisms on irinotecan-based regimens as the treatment in metastatic colorectal cancer , 2022 .